Methazolamide (Methazolamide) - Indications and Dosage

INDICATIONS AND USAGE

Methazolamide tablets are indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery.

DOSAGE AND ADMINISTRATION

The effective therapeutic dose administered varies from 50 mg to 100 mg two or three times daily. The drug may be used concomitantly with miotic and osmotic agents.

HOW SUPPLIED

Methazolamide Tablets USP, 25 mg, are round, white tablets, debossed “EFF” on one side and “21” on the other side and are supplied in bottles of 100, NDC 55806-021-03.

Methazolamide Tablets USP, 50 mg, are round, white, scored tablets debossed “EFF” on one side and “20” on the other side and are supplied in bottles of 100, NDC 55806-020-03.

Store at controlled room temperature, 15°-30°C (59°-86°F).

Dispense in a tight container as defined in the USP, with a child-resistant closure (as required).

CAUTION: Federal law prohibits dispensing without prescription.

Manufactured by:

MIKART, INC.

Atlanta, GA 30318

Marketed by:

EFFCON LABORATORIES, INC.

Marietta, GA 30065-1509

Code 617A00 & 628A00Rev. 10/93